WisdomAI and Teradata Partner to Deliver Agentic Intelligence for Mission-Critical Enterprise Data

Teradata (NYSE:TDC) reported flat Q2 revenue of $410M, beating estimates but missing guidance, causing its stock to drop 18.5%. C3.ai (NYSE:AI) saw a 25.5% revenue decline to $52.38M, meeting expectations but underperforming peers. Both companies' stocks reflect their earnings results.

Shares of Manhattan Associates, Agilysys, Guidewire Software, Pegasystems, and Teradata rose in afternoon trading after strong quarterly earnings and optimistic corporate commentary about AI-driven growth in enterprise software. Salesforce, CrowdStrike, and Okta reported significant AI-related revenue increases, easing investor concerns about AI disruption. Pegasystems' stock is down 36.2% year-to-date but saw a 6.2% increase on the day.

Teradata (TDC) reported Q2 revenue of $410M, above the $396.1M estimate, and adjusted EPS of $0.69 versus $0.56. Adjusted operating income was $88M. Management cited strong recurring revenue and margin improvement, plus a shift in on-premise contract revenue recognition that left sales flat YoY. Q3 revenue guidance midpoint was $395.2M, below estimates.

Teradata (NYSE:TDC) reported Q2 gross margin up 220 bps to 60.5% and recurring revenue gross margin up 30 bps to 67.8%, attributing outperformance to on-premise revenue recognition timing. Net cash rose to $323 million. The company repurchased about $40 million of stock and paid off $450 million of a term loan. It reaffirmed full-year guidance, raised non-GAAP EPS to $2.65-$2.73, and guided Q3 recurring revenue down 4%-2% and total revenue down 6%-4%.

Teradata reported Q2 2026 results with revenue of about $410M and net income of about $46M, alongside sales of about $363M. The company raised full-year GAAP diluted EPS guidance to $4.43 to $4.51. Teradata also launched an enterprise Data Analyst Agent on AWS Marketplace and added board member Bernd Leukert.

Teradata (TDC) reported Q2 adjusted EPS of 69 cents, above the 56-cent estimate, and sales of $410 million versus $397.1 million expected. For Q3, it guided adjusted EPS of 55 to 59 cents and sales of $391.0 to $399.4 million, both below estimates. FY2026 adjusted EPS was raised to $2.65-$2.73. Barclays cut its price forecast to $27. Shares fell 21.2% to $27.11.